Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy
NCT ID: NCT01486550
Last Updated: 2014-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
14 participants
INTERVENTIONAL
2011-12-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HES and Acute Kidney Injury in Adult Cardiac Surgery
NCT02445820
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
NCT06646328
Acute Renal Injury After Major Elective Non-Cardiac Surgery
NCT04600271
New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients
NCT02261909
Prevention of Acute Kidney Injury - Molecular Mechanisms of Dietary Pre-conditioning in Human
NCT02745444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Voluven (Hydroxyethyl starch 130/0,4)
Patients undergoing laparoscopic nephrectomy will receive either fluid therapy with active comparator (Voluven) or placebo (Sodium Chloride)
Voluven (Hydroxyethyl starch 130/0,4)
7,5 ml/kg in the first hour and then 5 ml/kg minimum
Sodium Chloride 9mg/ml
Patients undergoing laparoscopic nephrectomy will receive either fluid therapy with active comparator (Voluven) or placebo (Sodium Chloride)
Sodium Chloride 9mg/ml
7,5 ml/kg in the first hour and then 5 ml/kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Voluven (Hydroxyethyl starch 130/0,4)
7,5 ml/kg in the first hour and then 5 ml/kg minimum
Sodium Chloride 9mg/ml
7,5 ml/kg in the first hour and then 5 ml/kg
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males and females
* Indication for laparoscopic nephrectomy
Exclusion Criteria
* Lack of wish to participate
* eGFR\< 15ml/min
* Pregnancy or breast feeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regional Hospital Holstebro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erling Bjerregaard Pedersen
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Sophie P. Kancir, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Regional Hospital Holstebro
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medicinck forskningsafsnit, Regionshospitalet Holstebro
Holstebro, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASK-1-2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.